Home » EPIC Archives: IMM

IMM News Archives



ImmuPharma focused on expediting Lupuzor

Testing Lab

ImmuPharma plc (LON:IMM), (Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company, has today announced its final results for the twelve months ended 31 December 2019. Key Highlights (including ...

Read Article »